From gpesw@gadvisor.com  Thu Jun 21 13:35:03 2007
Return-Path: <gpesw@gadvisor.com>
Received: from plg2.math.uwaterloo.ca (plg2.math.uwaterloo.ca [129.97.186.80])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l5LHZ2L9027005
	for <theorize@flax9.uwaterloo.ca>; Thu, 21 Jun 2007 13:35:02 -0400
Received: from CPE-24-164-255-105.new.res.rr.com (CPE-24-164-255-105.new.res.rr.com [24.164.255.105])
	by plg2.math.uwaterloo.ca (8.13.8/8.13.8) with SMTP id l5LHYuXA008132
	for <theorize@plg.uwaterloo.ca>; Thu, 21 Jun 2007 13:34:59 -0400 (EDT)
Received: from zuafj ([211.159.134.172]) by CPE-24-164-255-105.new.res.rr.com with Microsoft SMTPSVC(6.0.3790.0); Thu, 21 Jun 2007 12:34:51 -0500
Message-ID: <001901c7b42a$78e99ab0$ac869fd3@zuafj>
From: "Cruz Christie" <gpesw@gadvisor.com>
To: <theorize@plg.uwaterloo.ca>
Subject: It's great to see this sort of thing happening: this is exactly why we need more young, enthusiastic, funded companies in the aging research space.
Date: Thu, 21 Jun 2007 12:34:51 -0500
MIME-Version: 1.0
Content-Type: multipart/related;
	type="multipart/alternative";
	boundary="----=_NextPart_000_0015_01C7B400.9006C170"
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook Express 5.50.4920.2300
X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4920.2300
X-Miltered: at mailchk-w02 with ID 467AB6C0.000 by Joe's j-chkmail (http://j-chkmail.ensmp.fr)!
X-Virus-Scanned: ClamAV version 0.90.3, clamav-milter version 0.90.3 on localhost
X-Virus-Status: Clean
X-UUID: 4c811427-3584-452d-95b7-58cd1791f1cd

------=_NextPart_000_0015_01C7B400.9006C170
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0016_01C7B400.9009F5C0"

------=_NextPart_001_0016_01C7B400.9009F5C0
Content-Type: text/plain;
	charset="windows-1250"
Content-Transfer-Encoding: quoted-printable


Success breeds further success, so we wish Elixir the best of luck in =
their work. That doesn't sound enticing at all. htmlLEF News is =
reprinting a businesswire article on Elixir Pharmaceuticals. Remind your =
friends that the US government is trying to legislate away the medicine =
they will need for a healthy future.
There are cartoons on the other channel, cakes on the table, and games =
played just down the road. The phrase "low-calorie diet" has also been =
seen here and there recently. As usual, it is clear that there are =
smart, capable, knowledgable people in the anti-aging research field who =
are woefully underfunded. This, in my opinion, is a direction in which =
the life extension, anti-aging and regenerative medicine advocates need =
to move.
But the mainstream doesn't have to listen to what we have to say if we =
present it in a fashion that is unappealing. SAGE Crossroads has a =
cautious and pro-regulatory editorial stance, alas, but the debates =
speak for themselves.
------=_NextPart_001_0016_01C7B400.9009F5C0
Content-Type: text/html;
	charset="windows-1250"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1250">
<META content=3D"MSHTML 5.50.4920.2300" name=3DGENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2><IMG alt=3D"assent" hspace=3D0=20
src=3D"cid:001401c7b42a$78d99520$ac869fd3@zuafj" align=3Dbaseline=20
border=3D0></FONT></DIV>
<DIV><FONT face=3DArial size=3D2>Success breeds further success, so we =
wish Elixir=20
the best of luck in their work. That doesn't sound enticing at all. =
htmlLEF News is=20
reprinting a businesswire article on Elixir Pharmaceuticals. Remind your =
friends=20
that the US government is trying to legislate away the medicine they =
will need for a=20
healthy future.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>There are cartoons on the other =
channel, cakes on=20
the table, and games played just down the road. The phrase "low-calorie =
diet" has=20
also been seen here and there recently. As usual, it is clear that there =
are smart,=20
capable, knowledgable people in the anti-aging research field who are =
woefully=20
underfunded. This, in my opinion, is a direction in which the life =
extension,=20
anti-aging and regenerative medicine advocates need to =
move.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>But the mainstream doesn't have to =
listen to what=20
we have to say if we present it in a fashion that is unappealing. SAGE =
Crossroads=20
has a cautious and pro-regulatory editorial stance, alas, but the =
debates speak for=20
themselves.</FONT></DIV></BODY></HTML>

------=_NextPart_001_0016_01C7B400.9009F5C0--

------=_NextPart_000_0015_01C7B400.9006C170
Content-Type: image/gif;
	name="videocassette.gif"
Content-Transfer-Encoding: base64
Content-ID: <001401c7b42a$78d99520$ac869fd3@zuafj>
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4^%

--%^V9^%--

------=_NextPart_000_0015_01C7B400.9006C170--

